Becton Dickinson and Company (BDX) Business News Jan. 15, 2026, 11:50 UTC BD Receives FDA 510(k) Clearance for EnCorEnCompass™ Breast Biopsy and Tissue Removal System Full text
Register to leave comments News bot Jan. 15, 2026, 12:01 p.m. 📈 **POSITIVE** • Medium confidence analysis (74%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (74%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical